An Hsu
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
-
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Cancer-related Molecular Pathways 2
-
- Cancer Genomics and Diagnostics 1
- Cancer, Hypoxia, and Metabolism 1
- MicroRNA in disease regulation 1
- Co-authors
- Shu‐Jen Chen (4 shared papers)Hua‐Chien Chen (4 shared papers)Yu‐Sun Chang (2 shared papers)Pao‐Hsien Chu (1 shared paper)Chien Yuh Yeh (2 shared papers)Hung‐Chih Hsu (2 shared papers)Wen‐Sy Tsai (2 shared papers)Chi‐Neu Tsai (1 shared paper)
- Journals
- Oncotarget (2 papers)Molecular Cancer Therapeutics (1 paper)International Journal of Molecular Sciences (1 paper)BioMed Research International (1 paper)American Journal of Transplantation (1 paper)
- Partner nations
- TaiwanUnited States
In The Last Decade
An Hsu
7 papers receiving 366 citations
Peers
Comparison fields: 5 of 58
- Transplantation 82
- Cancer Research 136
- Otorhinolaryngology 25
- Nephrology 31
- Oncology 116
Countries citing papers authored by An Hsu
This map shows the geographic impact of An Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Hsu more than expected).
Fields of papers citing papers by An Hsu
This network shows the impact of papers produced by An Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Hsu. The network helps show where An Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside An Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 97 | |
| 2 | 2015 | 85 | |
| 3 | 2014 | 80 | |
| 4 | 2015 | 49 | |
| 5 | 2015 | 29 | |
| 6 | 2018 | 24 | |
| 7 | 2023 | 5 |
About An Hsu
An Hsu is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 7 papers that have together received 369 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer-related Molecular Pathways (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Endometriosis Research and Treatment (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Transplantation (82 citations), Cancer Research (136 citations), Otorhinolaryngology (25 citations), Nephrology (31 citations) and Oncology (116 citations). An Hsu has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Shu‐Jen Chen, Hua‐Chien Chen, Yu‐Sun Chang, Pao‐Hsien Chu, Chien Yuh Yeh, Hung‐Chih Hsu, Wen‐Sy Tsai, Chi‐Neu Tsai, Tsai‐Sheng Yang and Yen‐Jung Lu. Their work appears in journals such as Oncotarget, Molecular Cancer Therapeutics, International Journal of Molecular Sciences, BioMed Research International and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.